Invasive Pulmonary Aspergillosis in a Critically Ill Neonate: Case Report and Review of Invasive Aspergillosis During the First 3 Months of Life
Citations Over TimeTop 10% of 1998 papers
Abstract
We report a fatal case of invasive pulmonary aspergillosis in a severely ill neonate and review 43 additional cases of invasive aspergillosis reported from 1955 through 1996 that occurred during the first 3 months of life. Eleven of the 44 patients had primary cutaneous aspergillosis, 10 had invasive pulmonary aspergillosis, and 14 had disseminated disease. Most infections were nosocomial in origin. Prematurity (43%); proven chronic granulomatous disease (14%); and a complex of diarrhea, dehydration, malnutrition, and invasive bacterial infections (23%) accounted for the majority of underlying conditions. At least 41% of the patients had received corticosteroid therapy before diagnosis, but only one patient had been neutropenic. Among patients who received medical and/or surgical treatment, outcome was relatively favorable, with an overall survival rate of 73%. Invasive aspergillosis may occur in neonates and young infants and warrants consideration under certain circumstances. Current therapeutic approaches consist of high-dose amphotericin B and appropriate surgical interventions.
Related Papers
- → Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism(1993)124 cited
- → Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study(1999)70 cited
- → Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis(2004)46 cited
- → Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis(2002)42 cited
- → Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: Difficulties in Establishing Correlation Between In Vitro Susceptibility Data and the Outcome of Initial Amphotericin B Therapy(2005)37 cited